Rani Therapeutics Holdings Class ARANI
13F holders, Q1 2025 (March 31)38holders −4
6new positions
10sold out
$1.27avg. 13F price*
At the end of Q1 2025, 38 institutions reported holding Rani Therapeutics Holdings Class A (RANI) in their 13F filings, down 4 from Q4 2024. 6 opened new positions and 10 sold out. The largest holders were Vanguard Group Inc. ($1.0M), Nan Fung Group Holdings Ltd ($622K) and Alphabet Inc. ($565K).
- Company
- Rani Therapeutics Holdings Class A
- CUSIP
- 753018100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $290K |
| Exits | 10 | $851K |
All 13F filers, Q4 2024 → Q1 2025: 451,741 shares bought and 661,819 shares sold, net −210,078 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 38 holders
| Vanguard Group Inc. | 0.00% | Add +12.7% | 799,679 | $1.0M |
| Nan Fung Group Holdings Ltd | 0.51% | No change | 493,584 | $622K |
| Alphabet Inc. | 0.04% | No change | 448,492 | $565K |
| United Services Automobile Association | 0.01% | No change | 302,743 | $412K |
| Takeda Pharmaceutical Co. Ltd. | 1.58% | No change | 203,190 | $256K |
| Geode Capital Management, LLC | 0.00% | Add +14.4% | 196,217 | $247K |
| Kestra Private Wealth Services, LLC | 0.00% | Add +16.3% | 139,156 | $175K |
| Northern Trust Corp. | 0.00% | Reduce -1.2% | 104,390 | $132K |
| CWA Asset Management Group, LLC | 0.01% | New | 83,333 | $105K |
| UBS Group AG | 0.00% | Add +206.6% | 72,117 | $91K |
| Forefront Wealth Partners, LLC | 0.06% | New | 65,000 | $82K |
| BlackRock, Inc. | 0.00% | No change | 63,583 | $80K |
| Lasry Marc | 0.36% | No change | 62,887 | $79K |
| State Street Corp. | 0.00% | No change | 62,442 | $79K |
| King Luther Capital Management Corp. | 0.00% | Add +75.8% | 58,000 | $73K |
| Motco | 0.01% | No change | 48,129 | $61K |
| Insigneo Advisory Services, LLC | 0.01% | No change | 47,500 | $60K |
| Bank of America Corp. | 0.00% | Reduce -37.1% | 46,640 | $59K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -17.7% | 46,500 | $59K |
| Gsa Capital Partners LLP | 0.01% | New | 44,633 | $56K |
| Brown Advisory Inc. | 0.00% | No change | 32,911 | $41K |
| Prime Capital Investment Advisors, LLC | 0.00% | No change | 27,208 | $34K |
| Janney Montgomery Scott LLC | 0.00% | No change | 27,200 | $34K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | New | 20,439 | $26K |
| Lafayette Investments, Inc. | 0.01% | No change | 19,893 | $25K |
| Susquehanna International Group, LLP | 0.00% | New | 16,554 | $21K |
| Morgan Stanley | 0.00% | Add +124.4% | 14,586 | $18K |
| Choreo, LLC | 0.00% | No change | 11,813 | $15K |
| XTX Topco Ltd | 0.00% | Reduce -14.7% | 10,996 | $14K |
| Cerity Partners LLC | 0.00% | No change | 10,000 | $13K |
| Islay Capital Management, LLC | 0.01% | No change | 9,611 | $12K |
| SBI Securities Co., Ltd. | 0.00% | Add +8.3% | 7,692 | $10K |
| Osaic Holdings, Inc. | 0.00% | Add +344.5% | 6,668 | $8K |
| Allworth Financial LP | 0.00% | No change | 3,119 | $3K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 2,000 | $3K |
| Citigroup Inc. | 0.00% | New | 313 | $394 |
| Stonebridge Financial Group, LLC | 0.00% | No change | 100 | $126 |
| JPMorgan Chase & Co. | 0.00% | No change | 71 | $89 |
"% of holder's portfolio" is RANI's weight in each manager's 13F, not the share of Rani Therapeutics Holdings Class A the manager owns.